Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05475574 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae in a Geriatric Unit

Study acronym: Ger-SP
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv9
  2. Primary completion date: Mar 10, 2025 to Sep 7, 2029
    • Study completion date: Mar 21, 2025 to Sep 21, 2029
    v8
  3. Re-verified, no change to tracked fieldsv7
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 10, 2023 to Mar 7, 2023
    v6
  5. Eligibility criteria expanded, about 14 wordsv5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: Jan 1, 2023 to Mar 10, 2023
    • Primary completion date: Jan 1, 2025 to Mar 10, 2025
    • Study completion date: Jan 12, 2025 to Mar 21, 2025
    v4
  2. Start date: Oct 1, 2022 to Jan 1, 2023
    • Primary completion date: Oct 1, 2024 to Jan 1, 2025
    • Study completion date: Oct 12, 2024 to Jan 12, 2025
    v3
  3. Start date: Sep 1, 2022 to Oct 1, 2022
    • Primary completion date: Sep 1, 2024 to Oct 1, 2024
    • Study completion date: Sep 12, 2024 to Oct 12, 2024
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is an interventional multicenter prospective noninferiority non-randomized double-blind controlled before and after study. The aim of this study is to demonstrate that standard precautions alone are not inferior to contact precautions by comparing the incidence density of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae acquired in geriatric units before and after discontinuing contact precautions.
Trial Details
NCT Number NCT05475574
Lead Sponsor Centre Hospitalier Régional Metz-Thionville
Conditions
(from sponsor)		 Infection, Hospital
Related terms Cross Infection
Enrollment 954 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov